Back

Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Prognosis after revascularisation in stable coronary artery disease Revascularisation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hristo Kirov

University hospital Jena, Jena (Germany)

5 More presentations in this session

Presentation thumbnail
In-hospital and 1-year mortality associated with percutaneous coronary intervention use in patients with acute myocardial infarction older than 90 years
Doctor F. Trombara (Milan, IT)
Abstract Slides
Presentation thumbnail
Interim prediction of two-year all-cause mortality in patients with de novo multivessel coronary artery disease undergoing intended multivessel PCI
Doctor M. Renkens (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Can machine learning improve risk prediction and individualise decision making between percutaneous and surgical revascularisation?
Doctor K. Ninomiya (Morioka, JP)
Abstract Slides Video
Presentation thumbnail
Predictors of periprocedural myocardial infarction after left main bifurcation percutaneous coronary intervention guided by optical coherence tomography imaging: the PREVENT study
Doctor A. Ricchiuto (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of percutaneous coronary intervention in chronic dialysis patients with acute myocardial infarction
Doctor F. Trombara (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis after revascularisation in stable coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Inter-relation between hypoxic liver injury and killip classification in st segment elevation myocardial infarction patients.
thumbnail
Congress Presentation
The association of steatotic liver disease with recurrent ischemic events in patients with chronic coronary syndrome: a multicenter cohort study
thumbnail
Congress Presentation
Pro-B-type natriuretic peptide strongly predicts major cardiovascular events and cardiovascular mortality in coronary artery disease patients with NAFLD as well as in those without NAFLD

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources